• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于丝氨酸蛋白酶纤溶酶的大环抑制剂。

Macrocyclic inhibitors for the serine protease plasmin.

机构信息

Department of Chemistry, Brown University, Providence, Rhode Island 02912, USA.

出版信息

J Enzyme Inhib Med Chem. 2009 Jun;24(3):779-94. doi: 10.1080/14756360802364401.

DOI:10.1080/14756360802364401
PMID:18825554
Abstract

Macrocyclic inhibitors for the serine protease plasmin were synthesized and evaluated. The inhibitors were constructed starting from a cyclohexanone core. This core was linked to either the C- or N-terminus of a peptide so that the inhibitors were designed to interact with the non-primed or primed binding sites of the protease. Macrocycles were prepared by connecting the side chain of Tyr or Trp, via a short linker, to one end of the peptide. The activities of the macrocyclic inhibitors, while modest, were up to 10-fold more potent than a related non-cyclic analog.

摘要

合成并评价了丝氨酸蛋白酶纤溶酶的大环抑制剂。抑制剂从环己酮核心构建。该核心连接到肽的 C-或 N-末端,使抑制剂设计为与蛋白酶的非引发或引发结合位点相互作用。通过短接头将 Tyr 或 Trp 的侧链连接到肽的一端,制备大环抑制剂。大环抑制剂的活性虽然中等,但比相关的非环类似物强 10 倍。

相似文献

1
Macrocyclic inhibitors for the serine protease plasmin.用于丝氨酸蛋白酶纤溶酶的大环抑制剂。
J Enzyme Inhib Med Chem. 2009 Jun;24(3):779-94. doi: 10.1080/14756360802364401.
2
Selective inhibitors of the serine protease plasmin: probing the S3 and S3' subsites using a combinatorial library.丝氨酸蛋白酶纤溶酶的选择性抑制剂:使用组合文库探究S3和S3'亚位点
J Med Chem. 2005 Nov 3;48(22):6908-17. doi: 10.1021/jm050488k.
3
Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.丝氨酸蛋白酶纤溶酶的环状酮抑制剂的构效关系研究:设计、合成及生物活性
Bioorg Med Chem. 2006 Dec 15;14(24):8467-87. doi: 10.1016/j.bmc.2006.08.040. Epub 2006 Sep 12.
4
Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease.基于分子建模的丙型肝炎NS3/4A蛋白酶强效P2-P4大环抑制剂研究方法
J Am Chem Soc. 2008 Apr 9;130(14):4607-9. doi: 10.1021/ja711120r. Epub 2008 Mar 14.
5
A comparison of cyclohexanone and tetrahydro-4H-thiopyran-4-one 1,1-dioxide as pharmacophores for the design of peptide-based inhibitors of the serine protease plasmin.环己酮和四氢-4H-硫代吡喃-4-酮1,1-二氧化物作为用于设计丝氨酸蛋白酶纤溶酶的肽基抑制剂的药效基团的比较。
J Org Chem. 2005 Oct 14;70(21):8309-21. doi: 10.1021/jo0508954.
6
Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease.基于间酪氨酸的丙型肝炎病毒NS3丝氨酸蛋白酶16元和17元大环抑制剂的设计、合成及生物活性
J Med Chem. 2005 Oct 6;48(20):6229-35. doi: 10.1021/jm050323b.
7
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles.源自脯氨酸基大环化合物的新型强效丙型肝炎病毒NS3丝氨酸蛋白酶抑制剂。
J Med Chem. 2006 Feb 9;49(3):995-1005. doi: 10.1021/jm050820s.
8
The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.丙型肝炎病毒NS3蛋白酶强效抑制剂的设计:BILN 2061——从核磁共振管到临床应用
Biopolymers. 2004;76(4):309-23. doi: 10.1002/bip.20127.
9
Proline-based macrocyclic inhibitors of the hepatitis C virus: stereoselective synthesis and biological activity.
Angew Chem Int Ed Engl. 2005 Nov 4;44(43):7024-8. doi: 10.1002/anie.200501553.
10
4-Heterocyclohexanone-based inhibitors of the serine protease plasmin.基于4-杂环己酮的丝氨酸蛋白酶纤溶酶抑制剂。
J Med Chem. 1999 Jul 29;42(15):2969-76. doi: 10.1021/jm990110k.

引用本文的文献

1
Mechanism-Based Macrocyclic Inhibitors of Serine Proteases.基于机制的丝氨酸蛋白酶大环抑制剂。
J Med Chem. 2024 Mar 28;67(6):4833-4854. doi: 10.1021/acs.jmedchem.3c02388. Epub 2024 Mar 13.
2
Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.用于治疗纤溶相关疾病的纤溶酶抑制剂的最新进展。
Med Res Rev. 2014 Nov;34(6):1168-216. doi: 10.1002/med.21315. Epub 2014 Mar 21.